ScholarIQanswers from OpenAlex & ORCID
Linda M. Liau
ResearcherPublications, citations & collaboration network
Linda M. Liau is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Linda M. Liau have?
ScholarIQindexed works
Linda M. Liau has 674 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Linda M. Liau have?
ScholarIQcitation count
Linda M. Liau has 35,211 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Linda M. Liau?
ScholarIQh-index
Linda M. Liau has an h-index of 83 in OpenAlex.
What is the i10-index of Linda M. Liau?
ScholarIQi10-index
Linda M. Liau has an i10-index of 207 in OpenAlex.
What is the ORCID of Linda M. Liau?
ScholarIQorcid
The ORCID for Linda M. Liau is on the source record.
What is the OpenAlex record for Linda M. Liau?
ScholarIQopenalex
The OpenAlex for Linda M. Liau is on the source record.
What are the most-cited papers on Linda M. Liau?
ScholarIQmost cited works
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Willy Hugo, Alex Lee, Tom B. Davidson, Anthony Wang, Benjamin M. Ellingson, Julie Rytlewski, Catherine Sanders, Eric S. Kawaguchi, Lin Du, Gang Li, William H. Yong, Sarah Gaffey, Adam L. Cohen, Ingo K. Mellinghoff, Eudocia Q. Lee, David A. Reardon, Barbara O’Brien, Nicholas Butowski, Phioanh L. Nghiemphu, Jennifer Clarke, Isabel Arrillaga‐Romany, Howard Colman, Thomas Kaley, John de Groot, Linda M. Liau, Patrick Y. Wen, Robert M. Prins
Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
Tim Cloughesy, Koji Yoshimoto, Phioanh L. Nghiemphu, Kevin R. Brown, Julie Dang, Shaojun Zhu, Teli Hsueh, Yinan Chen, Wei Wang, David Youngkin, Linda M. Liau, Neil A. Martin, Don Becker, Marvin Bergsneider, Albert Lai, Richard Green, Tom Oglesby, Michael Koleto, J.M. Trent, Steve Horvath, Paul S. Mischel, Ingo K. Mellinghoff, Charles L. Sawyers
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Albert Lai, Anh Tran, Phioanh L. Nghiemphu, Whitney B. Pope, Orestes E. Solis, Michael T. Selch, Emese Filka, William H. Yong, Paul S. Mischel, Linda M. Liau, Surasak Phuphanich, Keith L. Black, Scott Peak, Richard M. Green, Cynthia E. Spier, Tatjana Kolevska, Jonathan Polikoff, Louis Fehrenbacher, Robert M. Elashoff, Timothy F. Cloughesy
Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin
Albert Lai, Samir Kharbanda, Whitney B. Pope, Anh Tran, Orestes E. Solis, Franklin Peale, William F. Forrest, Kanan Pujara, Jose Carrillo, Ajay Pandita, Benjamin M. Ellingson, Chauncey W. Bowers, Robert Soriano, Nils Ole Schmidt, Sankar Mohan, William H. Yong, Somasekar Seshagiri, Zora Modrušan, Zhaoshi Jiang, Kenneth Aldape, Paul S. Mischel, Linda M. Liau, Cameron Escovedo, Weidong Chen, Phioanh L. Nghiemphu, C. David James, Michael D. Prados, Manfred Westphal, Katrin Lamszus, Timothy F. Cloughesy, Heidi Phillips
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Wei Chen, Timothy F. Cloughesy, Nirav Kamdar, Nagichettiar Satyamurthy, Marvin Bergsneider, Linda M. Liau, Paul S. Mischel, Johannes Czernin, Michael E. Phelps, Daniel Silverman